Back to search

Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

Data up to Jan 2025

Published1989
Citations203
References43

Total Citations Per Year

Abstract

References (43)

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1976 • 200,127 citations

THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY

1963 • 10,322 citations

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1980 • 8,534 citations

EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER

1985 • 496 citations

Oncological applications of somatostatin analogues.

1988 • 494 citations

Regulation of epidermal growth factor receptor by estrogen.

1985 • 379 citations

Steroid-hormone receptors in breast cancer

1984 • 327 citations

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1985 • 299 citations

Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

1984 • 279 citations

Somatostatin receptors in human endocrine tumors.

1987 • 253 citations

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.

1985 • 230 citations

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

1987 • 221 citations

Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

1984 • 201 citations

Radioiodinated Nondegradable Gonadotropin-Releasing Hormone Analogs: New Probes for the Investigation of Pituitary Gonadotropin-Releasing Hormone Receptors*

1979 • 198 citations

Epidermal growth factor receptors in human breast cancer

1984 • 190 citations

Steroid receptors in human breast cancer.

1978 • 172 citations

Gonadotropin-Releasing Hormone Binding Sites in Human Breast Carcinoma

1985 • 170 citations

Prostatic Epidermal Growth Factor Receptors and Their Regulation by Androgens*

1987 • 167 citations

TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER

1982 • 146 citations

Presence of somatomedin receptors on primary human breast and colon carcinomas

1987 • 141 citations

Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers

1984 • 133 citations

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

1986 • 118 citations

LHRH and its analogs : contraceptive and therapeutic applications

1984 • 111 citations

Treatment of Breast Cancer with Gonadotropin-Releasing Hormone

1986 • 89 citations

Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.

1988 • 86 citations

LHRH-Agonist treatment in clinical and experimental human breast cancer

1985 • 73 citations

Characterization of Pituitary Membrane Receptors for Somatostatin in the Rat*

1982 • 65 citations

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630

1986 • 57 citations

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist

1979 • 51 citations

Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.

1983 • 42 citations

Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.

1988 • 41 citations

Prognostic significance of prolactin receptors in human breast cancer.

1987 • 41 citations

Prolactin and luteinizing hormone‐releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer

1988 • 39 citations

Metabolism of steroid-modifying anticancer agents

1988 • 36 citations

Endocrine therapy of breast cancer

1988 • 34 citations

LHRH analogs for human mammary carcinoma

1984 • 33 citations

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents

1987 • 24 citations

Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist d-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer

1986 • 24 citations

Cultured mammary carcinoma cells contain gonadotropin‐releasing hormone‐like immunoreactivity, gnrh binding sites and chorionic gonadotropin

1987 • 23 citations

Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.

1988 • 14 citations

The clinical biology of hormone-responsive breast cancer

1988 • 14 citations

Somatostatin analogs in the treatment of various experimental tumors

1986 • 11 citations

Cited By (0)

Loading...
Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing… (1989) – Journal of Clinical Laboratory Analysis | Metascience Observatory Explorer